Advancing together and moving forward: Combination gene and cellular immunotherapies
Mol Ther Oncolytics
.
2022 May 30:25:330-334.
doi: 10.1016/j.omto.2022.05.005.
eCollection 2022 Jun 16.
Authors
Saul J Priceman
1
2
,
Waseem Cheema
3
,
Prasad S Adusumilli
3
4
Affiliations
1
Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, CA, USA.
2
Department of Immuno-Oncology, Beckman Research Institute of City of Hope, Duarte, CA, USA.
3
Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
4
Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
PMID:
35694448
PMCID:
PMC9160651
DOI:
10.1016/j.omto.2022.05.005
No abstract available
Publication types
Editorial
Grants and funding
R01 CA235667/CA/NCI NIH HHS/United States
P30 CA008748/CA/NCI NIH HHS/United States
P50 CA092131/CA/NCI NIH HHS/United States
R01 CA236615/CA/NCI NIH HHS/United States
P30 CA033572/CA/NCI NIH HHS/United States